1 Amputation |
6 |
|
Odds Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
1.1 Femoropopliteal lesions |
5 |
415 |
Odds Ratio (M‐H, Fixed, 95% CI) |
1.87 [0.40, 8.75] |
1.2 Tibial lesions |
1 |
72 |
Odds Ratio (M‐H, Fixed, 95% CI) |
1.0 [0.06, 16.63] |
2 Late lumen loss |
6 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
2.1 Femoropopliteal lesions |
5 |
423 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.65 [‐0.86, ‐0.45] |
2.2 Tibial lesions |
1 |
105 |
Mean Difference (IV, Fixed, 95% CI) |
0.02 [‐0.23, 0.27] |
3 Target lesion revascularization |
6 |
|
Odds Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
3.1 Femoropopliteal lesions |
5 |
423 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.22 [0.12, 0.41] |
3.2 Tibial lesions |
1 |
105 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.91 [0.26, 3.18] |
4 Binary restenosis |
5 |
|
Odds Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
4.1 Femoropopliteal lesions |
4 |
348 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.26 [0.15, 0.46] |
4.2 Tibial lesions |
1 |
105 |
Odds Ratio (M‐H, Fixed, 95% CI) |
1.85 [0.78, 4.39] |
5 Death |
6 |
|
Odds Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
5.1 Femoropopliteal lesions |
5 |
415 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.66 [0.22, 1.97] |
5.2 Tibial lesions |
1 |
72 |
Odds Ratio (M‐H, Fixed, 95% CI) |
2.06 [0.18, 23.77] |
6 Change in Rutherford category |
3 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
6.1 Femoropopliteal lesions |
2 |
177 |
Mean Difference (IV, Fixed, 95% CI) |
0.04 [‐0.42, 0.50] |
6.2 Tibial lesions |
1 |
72 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.60 [‐1.64, 0.44] |
7 Change in ankle‐brachial index |
4 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
7.1 Femoropopliteal lesions |
3 |
264 |
Mean Difference (IV, Random, 95% CI) |
0.07 [‐0.09, 0.22] |
7.2 Tibial lesions |
1 |
105 |
Mean Difference (IV, Random, 95% CI) |
‐0.2 [‐0.31, ‐0.09] |
8 Amputation (sensitivity analysis) |
3 |
|
Odds Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
8.1 Femoropopliteal lesions |
3 |
268 |
Odds Ratio (M‐H, Fixed, 95% CI) |
4.47 [0.49, 40.67] |
9 Late lumen loss (sensitivity analysis) |
3 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
9.1 Femoropopliteal lesions |
3 |
268 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.92 [‐1.27, ‐0.57] |
10 Target lesion revascularization (sensitivity analysis) |
3 |
|
Odds Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
10.1 Femoropopliteal lesions |
3 |
268 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.23 [0.11, 0.48] |
11 Binary restenosis (sensitivity analysis) |
2 |
|
Odds Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
11.1 Femoropopliteal lesions |
2 |
193 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.26 [0.12, 0.57] |
12 Death (sensitivity analysis) |
3 |
|
Odds Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
12.1 Femoropopliteal lesions |
3 |
268 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.57 [0.15, 2.11] |
13 Change in ankle‐brachial index (sensitivity analysis) |
2 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
13.1 Femoropopliteal lesions |
2 |
177 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.01 [‐0.09, 0.08] |